Inhibition of <i>Mycobacterium tuberculosis InhA</i> (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and <i>in-vitro</i> evidence-Reference-Cited by-同舟云学术

Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence

Published:2022-06-24 Issue: Volume: Page:1-19
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Dhivya L. S.¹^ORCID,Sarvesh Sabarathinam²^ORCID,S. Ankul Singh³

Affiliation:

1. Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kancheepuram, Tamil Nadu, India

2. Drug Testing Laboratory, Interdisciplinary Institute of Indian System of Medicine (IIISM), SRM Institute of Science and Technology, Kancheepuram, Tamil Nadu, India

3. Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kancheepuram, Tamil Nadu, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2086922

Reference49 articles.

1. Incipient and Subclinical Tuberculosis: Defining Early Disease States in the Context of Host Immune Response

2. A Profile of the In Vitro Anti-Tumor Activity and In Silico ADME Predictions of Novel Benzothiazole Amide-Functionalized Imidazolium Ionic Liquids

3. Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma

4. Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the Editor: Isolated Tuberculosis of the Wrist Joint Without Pulmonary;Surgical Infections;2024-05-01

2. In silico drug design strategies for discovering novel tuberculosis therapeutics;Expert Opinion on Drug Discovery;2024-02-19

3. Insight on sarcopenic obesity and epicatechin as a promising treatment option;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-10

4. Furan based synthetic chalcone derivative functions against gut inflammation and oxidative stress demonstrated in in-vivo zebrafish model;European Journal of Pharmacology;2023-10

5. Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents: in vitro, cytotoxicity assessment and in silico;Future Medicinal Chemistry;2023-09